TGC Ventures International, Inc. (TGVN) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Distribution Branche. Der Hauptsitz des Unternehmens ist in Atlanta, GA, United States. Der aktuelle CEO ist Michael Woo.
TGVN hat IPO-Datum 2014-11-03, gelistet an der Other OTC, eine Marktkapitalisierung von $120.00.
TGC Ventures International, Inc. operates early detection cancer clinics, using infra-red thermal imaging technology. The technology is used as diagnosis to determine structure changes in tissues to detect breast cancer. The company was formerly known as National Detection Clinics, Ltd. and changed its name to TGC Ventures International, Inc. in December 2005. TGC Ventures International, Inc. was incorporated in 2003 and is headquartered in Atlanta, Georgia.
